SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-061554
Filing Date
2023-11-09
Accepted
2023-11-09 08:05:31
Documents
63
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q phat-20230930.htm   iXBRL 10-Q 2194512
2 EX-31.1 phat-ex31_1.htm EX-31.1 15155
3 EX-31.2 phat-ex31_2.htm EX-31.2 15201
4 EX-32.1 phat-ex32_1.htm EX-32.1 9442
5 EX-32.2 phat-ex32_2.htm EX-32.2 9485
  Complete submission text file 0000950170-23-061554.txt   8734704

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT phat-20230930_def.xml EX-101.DEF 283320
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT phat-20230930.xsd EX-101.SCH 76468
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT phat-20230930_lab.xml EX-101.LAB 583324
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT phat-20230930_pre.xml EX-101.PRE 418255
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT phat-20230930_cal.xml EX-101.CAL 44621
57 EXTRACTED XBRL INSTANCE DOCUMENT phat-20230930_htm.xml XML 1355427
Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Filer) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39094 | Film No.: 231390163
SIC: 2834 Pharmaceutical Preparations